Logo image of ESTA

ESTABLISHMENT LABS HOLDINGS (ESTA) Stock Fundamental Analysis

NASDAQ:ESTA - Nasdaq - VGG312491084 - Common Stock - Currency: USD

37.41  -1.5 (-3.86%)

After market: 37.45 +0.04 (+0.11%)

Fundamental Rating

3

Overall ESTA gets a fundamental rating of 3 out of 10. We evaluated ESTA against 503 industry peers in the Health Care Equipment & Supplies industry. ESTA has a bad profitability rating. Also its financial health evaluation is rather negative. ESTA is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

ESTA had negative earnings in the past year.
ESTA had a negative operating cash flow in the past year.
ESTA had negative earnings in each of the past 5 years.
ESTA had a negative operating cash flow in each of the past 5 years.
ESTA Yearly Net Income VS EBIT VS OCF VS FCFESTA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M -80M -100M

1.2 Ratios

Looking at the Return On Assets, with a value of -26.73%, ESTA is in line with its industry, outperforming 44.92% of the companies in the same industry.
ESTA has a Return On Equity of -231.14%. This is in the lower half of the industry: ESTA underperforms 76.47% of its industry peers.
Industry RankSector Rank
ROA -26.73%
ROE -231.14%
ROIC N/A
ROA(3y)-29.75%
ROA(5y)-28.61%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ESTA Yearly ROA, ROE, ROICESTA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 400 -400 600 800

1.3 Margins

Looking at the Gross Margin, with a value of 66.35%, ESTA is in the better half of the industry, outperforming 70.05% of the companies in the same industry.
In the last couple of years the Gross Margin of ESTA has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for ESTA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 66.35%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.71%
GM growth 5Y1.49%
ESTA Yearly Profit, Operating, Gross MarginsESTA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

More info and screens

3

2. Health

2.1 Basic Checks

ESTA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ESTA has more shares outstanding
ESTA has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, ESTA has an improved debt to assets ratio.
ESTA Yearly Shares OutstandingESTA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
ESTA Yearly Total Debt VS Total AssetsESTA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

ESTA has an Altman-Z score of 0.86. This is a bad value and indicates that ESTA is not financially healthy and even has some risk of bankruptcy.
ESTA's Altman-Z score of 0.86 is in line compared to the rest of the industry. ESTA outperforms 46.52% of its industry peers.
A Debt/Equity ratio of 5.72 is on the high side and indicates that ESTA has dependencies on debt financing.
With a Debt to Equity ratio value of 5.72, ESTA is not doing good in the industry: 91.44% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 5.72
Debt/FCF N/A
Altman-Z 0.86
ROIC/WACCN/A
WACC8.42%
ESTA Yearly LT Debt VS Equity VS FCFESTA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

2.3 Liquidity

ESTA has a Current Ratio of 3.36. This indicates that ESTA is financially healthy and has no problem in meeting its short term obligations.
ESTA has a Current ratio (3.36) which is comparable to the rest of the industry.
ESTA has a Quick Ratio of 2.05. This indicates that ESTA is financially healthy and has no problem in meeting its short term obligations.
With a Quick ratio value of 2.05, ESTA perfoms like the industry average, outperforming 50.80% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.36
Quick Ratio 2.05
ESTA Yearly Current Assets VS Current LiabilitesESTA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

6

3. Growth

3.1 Past

ESTA shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 1.27%.
ESTA shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.27%.
ESTA shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.13% yearly.
EPS 1Y (TTM)1.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-20.69%
Revenue 1Y (TTM)9.27%
Revenue growth 3Y9.43%
Revenue growth 5Y13.13%
Sales Q2Q%11.33%

3.2 Future

ESTA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 25.95% yearly.
ESTA is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 34.17% yearly.
EPS Next Y30.89%
EPS Next 2Y28.18%
EPS Next 3Y24.87%
EPS Next 5Y25.95%
Revenue Next Year24.48%
Revenue Next 2Y24.51%
Revenue Next 3Y24.03%
Revenue Next 5Y34.17%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ESTA Yearly Revenue VS EstimatesESTA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2030 200M 400M 600M
ESTA Yearly EPS VS EstimatesESTA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 1 -1 -2 -3

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ESTA. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ESTA. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ESTA Price Earnings VS Forward Price EarningsESTA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ESTA Per share dataESTA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

A more expensive valuation may be justified as ESTA's earnings are expected to grow with 24.87% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y28.18%
EPS Next 3Y24.87%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ESTA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ESTABLISHMENT LABS HOLDINGS

NASDAQ:ESTA (6/17/2025, 8:00:01 PM)

After market: 37.45 +0.04 (+0.11%)

37.41

-1.5 (-3.86%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)08-04 2025-08-04/amc
Inst Owners105.29%
Inst Owner Change0.67%
Ins Owners7.45%
Ins Owner Change-5.05%
Market Cap1.08B
Analysts84.29
Price Target55.23 (47.63%)
Short Float %16.16%
Short Ratio7.79
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-30.34%
Min EPS beat(2)-75.04%
Max EPS beat(2)14.35%
EPS beat(4)2
Avg EPS beat(4)-18.37%
Min EPS beat(4)-75.04%
Max EPS beat(4)14.35%
EPS beat(8)5
Avg EPS beat(8)-8.71%
EPS beat(12)7
Avg EPS beat(12)-27.49%
EPS beat(16)9
Avg EPS beat(16)-25.84%
Revenue beat(2)0
Avg Revenue beat(2)-1.74%
Min Revenue beat(2)-2.16%
Max Revenue beat(2)-1.31%
Revenue beat(4)1
Avg Revenue beat(4)-1.4%
Min Revenue beat(4)-2.5%
Max Revenue beat(4)0.36%
Revenue beat(8)3
Avg Revenue beat(8)-1.53%
Revenue beat(12)6
Avg Revenue beat(12)-0.56%
Revenue beat(16)9
Avg Revenue beat(16)0.42%
PT rev (1m)-1.56%
PT rev (3m)-7.11%
EPS NQ rev (1m)1.14%
EPS NQ rev (3m)-3.2%
EPS NY rev (1m)0%
EPS NY rev (3m)-7.63%
Revenue NQ rev (1m)-1.37%
Revenue NQ rev (3m)-2.78%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.2%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 6.36
P/FCF N/A
P/OCF N/A
P/B 28.06
P/tB 41.97
EV/EBITDA N/A
EPS(TTM)-3.1
EYN/A
EPS(NY)-1.06
Fwd EYN/A
FCF(TTM)-2.7
FCFYN/A
OCF(TTM)-2.35
OCFYN/A
SpS5.89
BVpS1.33
TBVpS0.89
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -26.73%
ROE -231.14%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 66.35%
FCFM N/A
ROA(3y)-29.75%
ROA(5y)-28.61%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.71%
GM growth 5Y1.49%
F-Score3
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 5.72
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 112.27%
Cap/Sales 5.85%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.36
Quick Ratio 2.05
Altman-Z 0.86
F-Score3
WACC8.42%
ROIC/WACCN/A
Cap/Depr(3y)531.2%
Cap/Depr(5y)375.98%
Cap/Sales(3y)15.14%
Cap/Sales(5y)11.07%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-20.69%
EPS Next Y30.89%
EPS Next 2Y28.18%
EPS Next 3Y24.87%
EPS Next 5Y25.95%
Revenue 1Y (TTM)9.27%
Revenue growth 3Y9.43%
Revenue growth 5Y13.13%
Sales Q2Q%11.33%
Revenue Next Year24.48%
Revenue Next 2Y24.51%
Revenue Next 3Y24.03%
Revenue Next 5Y34.17%
EBIT growth 1Y11.57%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year45.63%
EBIT Next 3Y39.7%
EBIT Next 5Y50.21%
FCF growth 1Y22.53%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-0.22%
OCF growth 3YN/A
OCF growth 5YN/A